| Literature DB >> 29550146 |
James K Kirklin1, Rongbing Xie2, Jennifer Cowger3, Theo M M H de By4, Takeshi Nakatani5, Stephan Schueler6, Rhiannon Taylor7, Jenny Lannon7, Paul Mohacsi8, Jan Gummert8, Daniel Goldstein9, Kadir Caliskan8, Margaret M Hannan10.
Abstract
The second annual IMACS registry report includes over 14, 000 patients from 35 countries. Survival, adverse events, and an updated risk model is presented. Continuous flow pumps continue to dominate the world's experience. One and Two-year survival remains at 80% and 70%. Congenital heart disease and biventricular support are the most dominant risk factors. The database is poised for major novel analyses.Entities:
Keywords: IMACS; International Society for Heart and Lung Transplantation; adverse events; mechanical circulatory support; outcomes; risk factors; ventricular assist devices
Mesh:
Year: 2018 PMID: 29550146 DOI: 10.1016/j.healun.2018.01.1294
Source DB: PubMed Journal: J Heart Lung Transplant ISSN: 1053-2498 Impact factor: 10.247